Metformin Reduced Collagen Deposition and Contractility, but Increased Collagen Degradation in in vitro Posterior Capsule Opacification Model

Frisma Sagara Brilliyanto, Gatut Suhendro, Indri Wahyuni, Maftucah Rochmanti, Windhu Pramono

Abstract


BACKGROUND: Posterior capsule opacification (PCO) often occurs after cataract surgery. Metformin has been known to have an ability to inhibit fibrosis. This study aimed to investigate the effects of metformin on cell contractility, collagen deposition and degradation in human lens epithelial cells (HLEC) of cataract patients.

METHODS: HLEC were isolated from the anterior lens capsule of patients undergoing cataract surgery. The HLEC culture was carried out using explant culture technique. The in vitro PCO model was created by scratching technique on HLEC cultures. The treatment groups were given 0.1, 0.5 and 1 mM metformin, respectively, while the control group were given 10% fetal bovine serum (FBS). On the 7th day after scratching technique, the collagen deposition, collagen degradation and cell contractility were evaluated.

RESULTS: Collagen deposition in HLEC was significantly reduced after given 0.1 mM, 0.5 mM and 1 mM metformin (17.92±6.16 mg/mL, 12.92±4.31 mg/mL, 11.25±5.30 mg/mL, respectively), compared to the control group (31.46±7.52 μg/mL, p=0.002). Collagen degradation significantly was increased in the 0.1 mM, 0.5 mM and 1 mM metformin groups (4.77±9.27 mg/mL, 6.59±1.16 mg/mL, 6.35±1.90 mg/mL, respectively) compared to the control group (2.21±2.78 μg/mL, p=0.002). While, collagen contractility in HLEC was significantly reduced in 0.1mM, 0.5mM and 1 mM metformin groups (16.39±3.89%, 13.89±2.59%, 11.93±2.44%, respectively), compared to the control group (44.25±4.95%, p=0.000).

CONCLUSION: Metformin reduced collagen deposition and contractility, but increased collagen degradation in HLEC of cataract patients through mechanism of extracellular matrix remodeling.

KEYWORDS: metformin, human lens epithelial cell, fibrosis


Full Text:

PDF

References


Kansk JJ. Lens. Kanski’s Clinical Ophthalmology. 6th ed. New York: Elsevier Butterworth-Heinemann; 2007.

Bao X, Song H, Chen Z, Tang X. Wnt3a promotes epithelial-mesenchymal transition, migration, and proliferation of lens epithelial cells. Mol Vis. 2012; 18: 1983-90, PMID.

Jick SL, Beardsley TL, Brasington CR. Complications of cataract surgery, lens and cataract. Am Acad Ophthalmol. 2016; 137: 206-11.

Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017; 390: 600-12, CrossRef.

Zhang RP, Xie ZG. Research progress of drug prophylaxis for lens capsule opacification after cataract surgery. J Ophthalmol. 2020; 2020: 1-9, CrossRef.

Nibourg LM, Gelens E, Kuijer R, Hooymans JMM, van Kooten TG, Koopmans SA. Prevention of posterior capsular opacification. Exp Eye Res. 2015; 136: 100-15, CrossRef.

Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci. 2010; 118: 315-32, CrossRef.

Kalariya NM, Shoeb M, Ansari NH, Srivastava SK, Ramana KV. Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats. Investig Opthalmology Vis Sci. 2012; 53: 3431, CrossRef.

Bonnans C, Chou J, Werb Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014; 15: 786-801, CrossRef.

Ibaraki N. Human lens epithelial cell culture. In: Epithelial Cell Culture Protocols. New Jersey: Humana Press; 2002. p.1-6, CrossRef.

Stamm A, Reimers K, Strauß S, Vogt P, Scheper T, Pepelanova I. In vitro wound healing assays – state of the art. Bio Nano Materials. 2016; 17: 79-87, CrossRef.

Su S, Su S, Chen J. Collagen gel contraction assay. Protoc Exch. 2015: 2015: 082, CrossRef.

Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins: III. Analysis of tumors. Am J Clin Pathol. 1985; 84: 413-24, CrossRef.

Robinson-Bennett B, Han A. Role of Immunohistochemistry in Elucidating Lung Cancer Metastatic to the Ovary from Primary Ovarian Carcinoma. In: Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas. New York: Elsevier; 2005. p.537-45, CrossRef.

Auw-Haedrich C, Sundmacher R, Freudenberg N, Spelsberg H, Feltgen N, Maier P, et al. Expression of p63 in conjunctival intraepithelial neoplasia and squamous cell carcinoma. Graefes Arch Clin Exp Ophthalmol. 2006; 244: 96-103, CrossRef.

Eldred JA, Dawes LJ, Wormstone IM. The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci. 2011; 366: 1301-19, CrossRef.

Meacock WR. Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol. 2000; 84: 332-6, CrossRef.

Supriono S, Nugraheni A, Kalim H, Eko MH. The effect of gurcumin on regression of liver fibrosis through decreased expression of transforming growth factor-β1 (TGF-β1). Indones Biomed J. 2019; 11: 52-8, CrossRef.

Lu J, Shi J, Li M, Gui B, Fu R, Yao G, et al. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts. Life Sci. 2015; 127: 59-65, CrossRef.

Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, et al. Metformin attenuates cardiac fibrosis by inhibiting the TGFβ1–Smad3 signalling pathway. Cardiovasc Res. 2010; 87: 504-13, CrossRef.

Song Y, Chen Y, Li Y, Lyu X, Cui J, Cheng Y, et al. Metformin inhibits TGF-b1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway. Oncotarget. 2018; 9: 7023-35, CrossRef.

Barriere G, Tartary M, Rigaud M. Metformin: a rising star to fight the epithelial mesenchymal transition in Ooncology. Anticancer Agents Med Chem [Internet]. 2013; 13: 333-40, CrossRef.

Lasiste JM, Zoroquiain P, Miyamoto D, Burnier M. Metformin activity in an in vitro model of posterior capsule opacification. Vis Pan-America, Pan-American J Ophthalmol. 2018; 17: 105-12, CrossRef.




DOI: https://doi.org/10.18585/inabj.v13i2.1480

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute